Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · IEX Real-Time Price · USD
3.750
-0.140 (-3.60%)
At close: Jul 19, 2024, 4:00 PM
3.670
-0.080 (-2.13%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $111.04 million as of July 22, 2024.
Market Cap
111.04M
Enterprise Value
107.76M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $111.04M, a decrease of -46.43%. That is a compound annual growth rate of -75.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 111.00M | -46.45% |
| Feb 9, 2024 | 207.27M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KORU Medical Systems | 115.33M |
| FONAR | 115.17M |
| RAPT Therapeutics | 114.83M |
| TELA Bio | 114.15M |
| aTyr Pharma | 113.18M |
| Karyopharm Therapeutics | 110.91M |
| Adagene | 110.74M |
| Augmedix | 110.67M |